A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.

Shanping Shi Shazhou Ye Xiaoyue Wu Mingjun Xu Renjie Zhuo Qi Liao Yang Xi

Published in: Yonsei medical journal (2019)

The two-DNA methylation signature was deemed to be a potential novel prognostic biomarker of use in increasing the accuracy of predicting overall survival of ccRCC patients.

Keyphrases

dna methylation
end stage renal disease
gene expression
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
climate change
risk assessment
copy number